Erman, Aysegul

Chronic hepatitis C (CHC) is a leading cause of hepatic fibrosis and cirrhosis. Fortunately, treatment has been revolutionized by the recently introduced direct-acting antivirals (DAAs). However, prompt access to DAA therapy remains a challenge owing to exorbitant drug costs, as…